Drug Design & Medicinal Chemistry Congress26 - 27 October 2021 | London, UK
Bringing you the latest in enabling technologies, computational-based drug design and discovery chemistry. Key focus areas include: DNA-encoded libraries, protein-to-protein interactions, AI/ML in drug design, and medicinal chemistry for oncology
Drug Design and Medicinal Chemistry Congress includes...
Join over 400 leaders, experts and scientists at this event, helping to shape the future of discovery chemistry and computational drug design:
Learn about key focus areas include DNA encoded libraries, protein-protein interactions, AI/ML in drug design and new modalities such as Protein Degradation and Covalent Inhibitors.
Gain successful strategies in compound library development, DNA/RNA encoded libraries, protein to protein interaction, fragment and structured based drug design
Focusing on cutting edge tools, including: AI in ADME, big data management, model management, artificial intelligence, machine learning in drug design and AI in chemical synthesis, AI-enabled target ID capabilities, lead identification/optimisation
Engage in interactive discussions on the Integration Of DEL, Covalent Inhibitors and Protein Degradation Technologies In The Optimization Of HITs.
Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features.
Agenda at a Glance
Day One
Morning Sessions:
Stream 4: Computational Drug Design: AI Focus
Afternoon Interactive Roundtable Sessions:
Roundtable Discussions:
- Addressing Difficult Targets with New Novel Approaches in Drug Design
- AI in Drug Design – Where Are We?
- Digitising Drug Discovery Labs
- AI & Data Analysis
Workshop: Deploying 3D Modelling To Chemists
Day Two
Stream 3: Integration Of Technologies In The Optimization Of HITs – DEL, Covalent Inhibitors and Protein Degradation
Stream 4: Molecular Drug Design and Medicinal Chemistry
Interactive Roundtable Discussions:
- New Chemical Modalities and Challenging Targets: (Small and Large Molecules) and Choice of Modalities
- Covalent Inhibitors Design and Discovery – Overcoming Challenges
Key Speakers
The 2021 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Ian Storer
Malcolm Weir
Thorsten Thormann
Janet Brownlees
Sarah Stuart
Bryn Williams-Jones
Victor Neduva
Jake Bush
Eric Martin
